Oritavancin: Difference between revisions
From IDWiki
Content deleted Content added
Imported from text file |
(No difference)
|
Revision as of 17:58, 11 August 2019
Oritavancin
Classification
- Semisynthetic lipoglycopeptide antibiotic with very long half-life
Indications
- MRSA skin and soft tissue infections
Dosing
- IV once a week, long-acting
Renal Dosing
- Not required
